Author:
Anderegg Tamara R.,Biedenbach Douglas J.,Jones Ronald N.
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference7 articles.
1. Peptide deformylase as an antimicrobial drug target: target validation and resistance development;Apfel;Antimicrob. Agents Chemother.,1999
2. N-Alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity;Hackbarth;Antimicrob. Agents Chemother.,2002
3. Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor;Clements;Antimicrob. Agents Chemother.,2001
4. In vitro activities of peptide deformylase inhibitors against Gram-positive pathogens;Wise;Antimicrob. Agents Chemother.,2002
5. National Committee for Clinical Laboratory Standards. Approved Guideline M23-A2: Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters. 2nd ed. Wayne, PA: NCCLS, 2001.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献